Literature DB >> 18448428

SDF-1alpha promotes invasion of head and neck squamous cell carcinoma by activating NF-kappaB.

Aasia O Rehman1, Cun-Yu Wang.   

Abstract

CXCL12/stromal cell-derived factor-1alpha (SDF-1alpha), a chemokine ligand for the G protein-coupled receptor CXCR4, plays an important role in the directed movement of cells. Many studies have documented the importance of CXCR4 in tumor progression and organ-specific metastasis. Recently, several studies have implicated a role for SDF-1alpha in head and neck squamous cell carcinoma (HNSCC) metastasis, but currently there is little information about how SDF-1alpha promotes HNSCC metastasis. In this report we show that the NF-kappaB signaling pathway is activated in response to SDF-1alpha in HNSCC while primary and immortalized keratinocytes show no SDF-1alpha-mediated NF-kappaB activity. We found that SDF-1alpha-mediated NF-kappaB signaling is independent of phosphoinositide 3-kinase/Akt and ERK/MAPK pathways. We observed that SDF-1alpha induces IkappaBalpha phosphorylation and degradation and the nuclear translocation of NF-kappaB in HNSCC cell lines, suggesting that SDF-1alpha activates the classical NF-kappaB signaling pathway. Contrary to previous reports, SDF-1alpha-induced NF-kappaB activation is not mediated by tumor necrosis factor alpha. Furthermore, blocking the NF-kappaB signaling pathway with an IKKbeta inhibitor significantly reduces SDF-1alpha-mediated HNSCC invasion. Taken together, our data suggest SDF-1alpha/CXCR4 may promote HNSCC invasion and metastasis by activating NF-kappaB and that targeting NF-kappaB may provide therapeutic opportunities in preventing HNSCC metastasis mediated by SDF-1alpha.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448428      PMCID: PMC2459276          DOI: 10.1074/jbc.M710432200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways.

Authors:  R K Ganju; S A Brubaker; J Meyer; P Dutt; Y Yang; S Qin; W Newman; J E Groopman
Journal:  J Biol Chem       Date:  1998-09-04       Impact factor: 5.157

2.  Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1.

Authors:  T Nagasawa; S Hirota; K Tachibana; N Takakura; S Nishikawa; Y Kitamura; N Yoshida; H Kikutani; T Kishimoto
Journal:  Nature       Date:  1996-08-15       Impact factor: 49.962

3.  Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines.

Authors:  F G Ondrey; G Dong; J Sunwoo; Z Chen; J S Wolf; C V Crowl-Bancroft; N Mukaida; C Van Waes
Journal:  Mol Carcinog       Date:  1999-10       Impact factor: 4.784

4.  Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin.

Authors:  T Nagasawa; T Nakajima; K Tachibana; H Iizasa; C C Bleul; O Yoshie; K Matsushima; N Yoshida; T A Springer; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta.

Authors:  Q Zhao; F S Lee
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

6.  Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.

Authors:  D C Duffey; Z Chen; G Dong; F G Ondrey; J S Wolf; K Brown; U Siebenlist; C Van Waes
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

7.  The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.

Authors:  G Dong; Z Chen; T Kato; C Van Waes
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

8.  Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1.

Authors:  H Nakano; M Shindo; S Sakon; S Nishinaka; M Mihara; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

9.  Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase.

Authors:  S Nemoto; J A DiDonato; A Lin
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

10.  Molecular cloning and structure of a pre-B-cell growth-stimulating factor.

Authors:  T Nagasawa; H Kikutani; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

View more
  16 in total

1.  BCL10 is recruited to sites of DNA damage to facilitate DNA double-strand break repair.

Authors:  Ismail Hassan Ismail; Ashley Dronyk; Xiuying Hu; Michael J Hendzel; Andrew R Shaw
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

2.  EPS8 upregulates FOXM1 expression, enhancing cell growth and motility.

Authors:  Huixin Wang; Muy-Teck Teh; Youngmi Ji; Vyomesh Patel; Shahrzad Firouzabadian; Anisha A Patel; J Silvio Gutkind; W Andrew Yeudall
Journal:  Carcinogenesis       Date:  2010-03-29       Impact factor: 4.944

3.  Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma.

Authors:  Xavier León; Santiago Diez; Jacinto García; Joan Lop; Anna Sumarroca; Miquel Quer; Mercedes Camacho
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-21       Impact factor: 2.503

4.  Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow.

Authors:  Younghun Jung; Jingcheng Wang; Eunsohl Lee; Samantha McGee; Janice E Berry; Kenji Yumoto; Jinlu Dai; Evan T Keller; Yusuke Shiozawa; Russell S Taichman
Journal:  Mol Cancer Res       Date:  2014-08-19       Impact factor: 5.852

5.  Integrating chemotaxis and contact-inhibition during collective cell migration: Small GTPases at work.

Authors:  Eric Theveneau; Roberto Mayor
Journal:  Small GTPases       Date:  2010-09

6.  Identification of tetranectin as a potential biomarker for metastatic oral cancer.

Authors:  Martha E Arellano-Garcia; Roger Li; Xiaojun Liu; Yongming Xie; Xiaofei Yan; Joseph A Loo; Shen Hu
Journal:  Int J Mol Sci       Date:  2010-09-02       Impact factor: 5.923

7.  Differential expression of SDF-1 isoforms in bladder cancer.

Authors:  Miguel Gosalbez; Marie C Hupe; Soum D Lokeshwar; Travis J Yates; John Shields; Muthu K Veerapen; Axel S Merseburger; Charles J Rosser; Mark S Soloway; Vinata B Lokeshwar
Journal:  J Urol       Date:  2013-11-26       Impact factor: 7.450

8.  C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury.

Authors:  Hongyan Mo; Qinyu Wu; Jinhua Miao; Congwei Luo; Xue Hong; Yongping Wang; Lan Tang; Fan Fan Hou; Youhua Liu; Lili Zhou
Journal:  Antioxid Redox Signal       Date:  2017-03-28       Impact factor: 8.401

9.  An orthotopic murine model of sinonasal malignancy.

Authors:  Alexander Gelbard; Michael E Kupferman; Samar A Jasser; Wantao Chen; Adel K El-Naggar; Jeffrey N Myers; Ehab Y Hanna
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

10.  A novel CXCR4 antagonist derived from human SDF-1beta enhances angiogenesis in ischaemic mice.

Authors:  Yi Tan; Yan Li; Jian Xiao; Hongwei Shao; Chuanlin Ding; Gavin E Arteel; Keith A Webster; Jun Yan; Hong Yu; Lu Cai; Xiaokun Li
Journal:  Cardiovasc Res       Date:  2009-02-05       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.